Latest news updates... Oct 12
Latest pharma news update... Sep 29
The authorization is specifically for those with mild-to-moderate Covid-19, who are at risk of getting much sicker... May 27
The move comes after the detection of different Covid variants ... Mar 26
Teplizumab, Provention Bio’s lead drug candidate, is an anti-CD3 monoclonal antibody (mAb) being developed for the delay or prevention of type 1 diabetes ... Aug 29
-Advertisements-